-- Chord Energy (CHRD) 週二公佈，其 2026 年第一季石油日產量為 15.8 萬桶，高於先前預期的 15.25 萬桶至 15.55 萬桶。 天然氣凝析液日產量為 4.9 萬桶，與公司預期上限相符。 天然氣日產量也超出預期，達到 4.114 億立方英尺，高於先前預期的 4.01 億立方英尺至 4.09 億立方英尺。 Chord Energy 表示，受石油產量成長和資本支出按計畫進行的支持，本季經營活動現金流和調整後自由現金流均超出預期。 該公司表示，由於鑽井、完井和生產業績穩健，將2026年全年石油產量預期上調2,000桶/日至16.1萬桶/日，同時維持資本預算不變。 該公司還更新了其首個完整的4英里開發項目進展，稱已成功完成並投產了五口井的Toonie井場。 該公司表示，專案進展符合預期。
Related Articles
Asia
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
$HKG:2096
Asia
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
$HKG:1357
Asia
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.
$HKG:2158